°£³»´ã¼®Áõ ¹× º´¹ßµÈ ´ã°ü¾ÏÁ¾À¸·Î ÀýÁ¦µÈ °£ Á¶Á÷³» ÁÖ´ã°ü »óÇÇÀÇ Áõ½Ä¼¼Æ÷ÇÙÇ׿ø ¹ßÇö
Expression of Proliferating Cell Nuclear Antigen (PCNA) of Major Intrahepatic Bile Duct Epithelium in Resected Liver Tissue with Hepatolithiasis and Hepatolithiasis Associated with Cholangiocarcinoma
À̽ó», ¼º¼øÈñ, ÇÑ¿î¼·,
¼Ò¼Ó »ó¼¼Á¤º¸
À̽ó» ( Lee Shi-Nae )
ÀÌÈ¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
¼º¼øÈñ ( Sung Sun-Hee )
ÀÌÈ¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
ÇÑ¿î¼· ( Han Woon-Sup )
ÀÌÈ¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
KMID : 0357920020360040232
Abstract
Background: Histologic progressive changes of bile duct epithelium with hyperplasia, dysplasia and cholangiocarcinoma could be caused by hepatolithiasis. To be clarified as a neoplastic process, this histologic process should be evaluated with various aspects of cell biology.
Methods: Immunohistochemical study of proliferating cell nuclear antigen (PCNA) was performed on 45 cases (10; normal, 15; hyperplasia, 14; low-grade dysplasia:LGD, 6; high-grade dysplasia: HGD) of hepatolithiasis and 10 cases (all HGD) of hepatolithiasis with cholangiocarcinoma.
Results: In the hepatolithiasis, mean PCNA labelling indices (LI) of normal, hyperplasia, LGD and HGD of major intrahepatic bile duct epithelium were 24.5+/-4.3, 51.5+/-0.1, 62.0+/-.4 and 84.7+/-.3, respectively and gradually increased. Mean LI of PCNA in HGD of major intrahepatic bile duct epithelium of hepatolithiasis with cholangiocarcinoma was 68.7+/-.7, which was similar to that of LGD in hepatolithiasis without cholangiocarcinoma.
Conclusion:> Histologic transformation through hyperplasia, dysplasia and carcinoma in major intrahepatic bile duct epithelium of hepatolithiasis may be a neoplastic process if these histologic changes are evaluated in the cellular proliferation aspect.
Å°¿öµå
Proliferating Cell Nuclear Anrigen;Bile Duct Diseases;Cholangiocarcinoma
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸